We’re launching an urgent research project and we need your help
How do arthritis patients react to COVID-19?
You may have heard about some small-scale research studies testing whether chloroquine and hydroxychloroquine — drugs commonly used by people with rheumatoid arthritis and lupus — are effective at treating COVID-19.
We urgently need a large-scale, well-designed research project to examine the connections between these drugs and COVID-19 and to determine what it means for people with arthritis, who have immune systems that leave them vulnerable to infections.
The research could save the lives of people with and without arthritis in Canada and around the world.
A team of Canadian researchers is uniquely positioned to launch this research. And they are anxious to get going.
We need your help to get them started.
We need to raise $300,000 to get the research off the ground today, and to support other research like it that focuses on the body’s internal defense mechanisms.
The initiative will also accelerate and invest in 12 immune system projects currently underway with $1.5 million in Arthritis Society funding. This research is critical to uncovering the molecular markers involved in arthritis and how the immune system responds under stress.
We can learn a lot from arthritis patients already taking these medications.